Pharmacoeconomic Assessment of Sucroferric Oxyhydroxide Vs Sevelamer Carbonate In Patients With Chronic Kidney Disease In Belgium and The Netherlands
Abstract
Authors
N Kotsopoulos M Connolly P Vrouchou S Walpen H Smeenge J van Stiphout